Table 3

Human papillomavirus (HPV) types in women ≤40 years by Indigenous status, n (%)

HPV type

Non-Indigenous women

(n = 1494)

Indigenous women

(n = 655)


6

47 (3.1%)

13 (2.0%)

11

9 (0.6%)

6 (0.9%)

16a

141 (9.4%)

69 (10.5%)

18a

62 (4.1%)

25 (3.8%)

2

0

1 (0.2%)

31a

56 (3.7%)

22 (3.4%)

33a

31 (2.1%)

18 (2.7%)

35a

16 (1.1%)

14 (2.1%)

39a

58 (3.9%)

24 (3.7%)

40

16 (1.1%)

4 (0.6%)

42

61 (4.1%)

19 (2.9%)

45a

23 (1.5%)

15 (2.3%)

51a

94 (6.3%)

37 (5.6%)

52a

57 (3.8%)

36 (5.5%)

53

82 (5.5%)

34 (5.2%)

54

49 (3.3%)

24 (3.7%)

55

29 (1.9%)

8 (1.2%)

56a

39 (2.6%)

16 (2.4%)

58a

44 (2.9%)

20 (3.1%)

59a

39 (2.6%)

22 (3.4%)

61

56 (3.7%)

33 (5.0%)

62

65 (4.4%)

35 (5.3%)

64

1 (0.1%)

0

66

61 (4.1%)

23 (3.5%)

67

24 (1.6%)

8 (1.2%)

68a,b

13 (0.9%)

21 (3.2%)

69

1 (0.1%)

4 (0.6%)

70b

21 (1.4%)

28 (4.3%)

71b

1 (0.1%)

7 (1.1%)

72c

2 (0.1%)

7 (1.1%)

73

40 (2.7%)

21 (3.2%)

81b

20 (1.3%)

29 (4.4%)

82 (previously IS39) [29]

20 (1.4%)

10 (1.6%)

83

19 (1.3%)

15 (2.3%)

84

61 (4.1%)

19 (2.9%)

89 (previously CP6108) [29]

68 (4.6%)

31 (4.7%)

No type detectedb

879 (58.8%)

332 (50.6%)

Multiple

354 (23.7%)

180 (27.4%)

16/18

185 (12.5%)

86 (13.1%)

6/11/16/18

220 (14.7%)

102 (15.5%)


16/18 only

44 (2.9%)

21 (3.2%)


6/11/16/18 only

53 (3.5%)

26 (4.0%)


aEstablished high-risk HPV type.

bχ2 P < 0.001.

cχ2 P = 0.002.

Garland et al. BMC Medicine 2011 9:104   doi:10.1186/1741-7015-9-104

Open Data